Rakuten Medical, Inc.
Biotechnology · San Diego, CA
BiotechnologySEC Form D
Rakuten Medical, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 13, 2026, reporting $111,522,289 raised toward a $116,672,752 offering.
Incorporated in Delaware and based in San Diego, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Rakuten Medical, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Maeda MinamiExecutive Officer
- David ChaoDirector
- Mazen DarwazahDirector
- Miguel Garcia-GuzmanDirector
- Kentaro HyakunoDirector
- Hiroshi MikitaniExecutive Officer · Director
- Hiroshi MoriDirector
- Nitin NohriaDirector
- Eiichi KagaDirector
- Tiffany PiecewiczExecutive Officer
- Abhijit BhatiaExecutive Officer
- Carlos GarciaExecutive Officer
- Toshiaki SuzukiExecutive Officer
- Hiroyuki KodamaExecutive Officer
- Suzane SanExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised